Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-07-01 @ 4:46 PM
Study NCT ID:
NCT05165433
Status:
COMPLETED
Last Update Posted:
2025-12-16
First Post:
2021-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)
Sponsor:
Akamis Bio
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NG-350A-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |